Imre Health has recruited Digitas Health's Shane McDevitt as director of its medical and scientific affairs unit.
As medical editor at Digitas Health, McDevitt specialized in oncology brands. He will lead a team responsible for new therapies across the pharmaceutical, biotech and biopharmaceutical categories, while integrating medical and scientific savvy into existing practices.
Imre, which handles clients such as AstraZeneca, GlaxoSmithKline, Pfizer, Bausch Health and EQRx, ranked No. 8 on O'Dwyer's 2020 rankings of independent healthcare firms with fees of $21M.
Jeff Smokler, President of Imre Health, said his goal is to build a new agency model, where medicine and science sit among—rather than adjacent to—the integrated suite of strategic and creative services the agency delivers.
The firm added Josh Simon as VP-social health marketing earlier this year. He joined from AstraZeneca.
Imre has offices in Baltimore, Philadelphia, New York and Los Angeles.